SEARCH RESULTS FOR: "Tag: CLDX"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(1)
2016(3)
2015(6)
2014(2)
CATEGORIES
Analyst Update(1)
Buzz Stocks(3)
Expectational Analysis(1)
General(3)
Intraday Option Activity(2)
Stock Market News(1)
Stocks On the Move(3)

4/16/2018 9:55 AM
Biopharmaceutical stock Alkermes Plc (NASDAQ:ALKS) is rallying this morning after the U.S. Food and Drug Administration (FDA) accepted the company's new drug application (NDA) for ALKS 5461, a treatm...
3/8/2016 2:19 PM
Analysts are weighing in on biotech Celldex Therapeutics, Inc. (NASDAQ:CLDX), oil-and-gas stock EP Energy Corp (NYSE:EPE), and Sam Adams parent Boston Beer Co Inc (NYSE:SAM). Here's a quick roundup of...
3/7/2016 10:08 AM
U.S. stocks are slightly lower this morning, despite rising crude oil futures. Among equities in focus are chemical giant DuPont (NYSE:DD), drugmaker Celldex Therapeutics, Inc. (NASDAQ:CLDX), and sem...
2/25/2016 9:28 AM
Stocks are pointed higher ahead of the bell amid stabilizing oil prices. Meanwhile, among specific equities in focus are electronics retailer Best Buy Co Inc (NYSE:BBY), drugmaker Celldex Therapeuti...
11/23/2015 11:20 AM
New Jersey-based biotech stock Celldex Therapeutics, Inc. (NASDAQ:CLDX) typically flies under the radar of most options traders, with average daily volume for CLDX amounting to fewer than 1,600 calls...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center